Sickle-cell thalassemia, unspecified, with cerebral vascular involvement is a genetic blood disorder characterized by the presence of both sickle cell disease and thalassemia. This condition can lead to various complications, including cerebrovascular events due to impaired blood flow. Accurate coding with ICD-10 Code D57.413 is essential for proper diagnosis, documentation, medical billing, and public health reporting, ensuring that patients receive appropriate care and resources.
ICD-10 Code D57.413 represents sickle-cell thalassemia, unspecified, with cerebral vascular involvement. This code is used when a patient presents with complications related to both sickle cell disease and thalassemia, specifically affecting the cerebral vasculature. It is crucial for clinical documentation and billing to accurately reflect the patient's condition and ensure appropriate treatment and resource allocation.
Sickle-cell thalassemia, unspecified, with cerebral vascular involvement is caused by a combination of genetic mutations leading to abnormal hemoglobin production. This results in sickle-shaped red blood cells that can obstruct blood flow, particularly in the brain, leading to potential strokes or transient ischemic attacks. Prompt medical attention is necessary to manage symptoms and prevent complications.
ICD-10 Code D57.413 is utilized in SOAP notes to document the patient's symptoms, assessment findings, and treatment plans. This code is relevant in both acute and chronic care settings, ensuring comprehensive documentation of the patient's condition and facilitating appropriate management strategies.
In SOAP notes, ICD-10 Code D57.413 connects subjective patient-reported symptoms and objective clinical findings to a formal diagnosis. This code plays a critical role in ensuring continuity of care, supporting accurate billing, and meeting EHR documentation standards.
Management of sickle-cell thalassemia with cerebral vascular involvement requires urgent medical intervention. Treatment focuses on preventing complications and managing symptoms.


HIPAA-compliant and designed with privacy in mind, your patient’s data is protected. Focus on care while we safeguard your information.
Learn moreICD-10 Code D57.413 is critical in medical billing, particularly in hospital, emergency room, or infectious disease care settings.
| CPT Code | Description |
|---|---|
| 36430 | Transfusion of blood products. |
| 99285 | Emergency department visit, high severity. |
| 93000 | Electrocardiogram, ECG. |
Common Questions About Using ICD-10 Code D57.413 for Sickle-cell thalassemia, unsp, with cerebral vascular invl
What are the common symptoms of sickle-cell thalassemia with cerebral vascular involvement?
Common symptoms include recurrent headaches, dizziness, fatigue, and neurological deficits. Patients may also experience pain crises due to vaso-occlusive events.
How is sickle-cell thalassemia with cerebral vascular involvement treated?
Treatment typically involves hydration, pain management, blood transfusions, and preventive measures against infections. Regular monitoring is essential to manage complications.
When should ICD-10 Code D57.413 be used?
This code should be used when documenting cases of sickle-cell thalassemia with complications affecting the cerebral vasculature, particularly in acute care settings.
What is the importance of accurate coding for D57.413?
Accurate coding ensures proper diagnosis, facilitates appropriate treatment, supports billing processes, and aids in public health reporting.
Clinical Notes
SOAP notes
DAP notes
AI medical notes